» Articles » PMID: 36189922

S6K1 Phosphorylates Cdk1 and MSH6 to Regulate DNA Repair

Abstract

The mTORC1 substrate, S6 Kinase 1 (S6K1), is involved in the regulation of cell growth, ribosome biogenesis, glucose homeostasis, and adipogenesis. Accumulating evidence has suggested a role for mTORC1 signaling in the DNA damage response. This is mostly based on the findings that mTORC1 inhibitors sensitized cells to DNA damage. However, a direct role of the mTORC1-S6K1 signaling pathway in DNA repair and the mechanism by which this signaling pathway regulates DNA repair is unknown. In this study, we discovered a novel role for S6K1 in regulating DNA repair through the coordinated regulation of the cell cycle, homologous recombination (HR) DNA repair (HRR) and mismatch DNA repair (MMR) mechanisms. Here, we show that S6K1 orchestrates DNA repair by phosphorylation of Cdk1 at serine 39, causing G2/M cell cycle arrest enabling homologous recombination and by phosphorylation of MSH6 at serine 309, enhancing MMR. Moreover, breast cancer cells harboring gene amplification show increased resistance to several DNA damaging agents and S6K1 expression is associated with poor survival of breast cancer patients treated with chemotherapy. Our findings reveal an unexpected function of S6K1 in the DNA repair pathway, serving as a tumorigenic barrier by safeguarding genomic stability.

Citing Articles

Role of PI3 Kinases in Cell Signaling and Soleus Muscle Atrophy During Three Days of Unloading.

Zaripova K, Belova S, Kostrominova T, Shenkman B, Nemirovskaya T Int J Mol Sci. 2025; 26(1.

PMID: 39796270 PMC: 11720661. DOI: 10.3390/ijms26010414.


RNA Sequencing and Weighted Gene Co-Expression Network Analysis Highlight DNA Replication and Key Genes in Nucleolin-Depleted Hepatoblastoma Cells.

Steinkellner H, Madritsch S, Kluge M, Seipel T, Sarne V, Huber A Genes (Basel). 2025; 15(12.

PMID: 39766782 PMC: 11675179. DOI: 10.3390/genes15121514.


Proapoptotic role of CDK1 in overcoming paclitaxel resistance in ovarian cancer cells in response to combined treatment with paclitaxel and duloxetine.

Kim G, Jang S, Ahn S, Kim S, Park C, Seong M Cancer Cell Int. 2024; 24(1):409.

PMID: 39702300 PMC: 11660910. DOI: 10.1186/s12935-024-03607-8.


SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage.

Lepore Signorile M, Sanese P, Di Nicola E, Fasano C, Forte G, De Marco K Cells. 2023; 12(22).

PMID: 37998381 PMC: 10670288. DOI: 10.3390/cells12222644.


TOR complex 1 negatively regulates NDR kinase Cbk1 to control cell separation in budding yeast.

Foltman M, Mendez I, Bech-Serra J, de la Torre C, Brace J, Weiss E PLoS Biol. 2023; 21(8):e3002263.

PMID: 37647291 PMC: 10468069. DOI: 10.1371/journal.pbio.3002263.


References
1.
Shen C, Houghton P . The mTOR pathway negatively controls ATM by up-regulating miRNAs. Proc Natl Acad Sci U S A. 2013; 110(29):11869-74. PMC: 3718104. DOI: 10.1073/pnas.1220898110. View

2.
Smits V, Medema R . Checking out the G(2)/M transition. Biochim Biophys Acta. 2001; 1519(1-2):1-12. DOI: 10.1016/s0167-4781(01)00204-4. View

3.
Lai K, Leong W, Chau J, Jia D, Zeng L, Liu H . S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response. EMBO J. 2010; 29(17):2994-3006. PMC: 2944047. DOI: 10.1038/emboj.2010.166. View

4.
Bae-Jump V, Zhou C, Boggess J, Gehrig P . Synergistic effect of rapamycin and cisplatin in endometrial cancer cells. Cancer. 2009; 115(17):3887-96. DOI: 10.1002/cncr.24431. View

5.
Ben-Hur V, Denichenko P, Siegfried Z, Maimon A, Krainer A, Davidson B . S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1. Cell Rep. 2013; 3(1):103-15. PMC: 5021319. DOI: 10.1016/j.celrep.2012.11.020. View